MDSR 2024: Clinical Higher Risk MDS
Vložit
- čas přidán 8. 07. 2024
- Overview of the treatment for HR-MDS - Pierre Fenaux
New drugs including Abs and BCL2-inhibitor for HRMDS -
Guillermo Garcia-Manero
Azacitidine Treatment - Yasuhito Nannya
CLK inhibitor - Seishi Ogawa
Transplantation or practical treatment for HR-MDS in Japan - Kensuke Usuki